US6706694B1
(en)
|
1990-03-21 |
2004-03-16 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences in a vertebrate
|
US6228844B1
(en)
|
1991-11-12 |
2001-05-08 |
Vical Incorporated |
Stimulating vascular growth by administration of DNA sequences encoding VEGF
|
FR2705686B1
(fr)
*
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
AU727970B2
(en)
*
|
1993-05-28 |
2001-01-04 |
Transgene S.A. |
Defective adenoviruses and corresponding complementation lines
|
AU7404994A
(en)
*
|
1993-07-30 |
1995-02-28 |
Regents Of The University Of California, The |
Endocardial infusion catheter
|
US6682728B1
(en)
*
|
1993-10-13 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Efficient and selective adenoviral-mediated gene transfer into vascular neointima
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
US6040157A
(en)
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
DK0751992T3
(da)
|
1994-03-08 |
2006-03-06 |
Human Genome Sciences Inc |
Karendotelvækstfaktor 2
|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
FR2718150B1
(fr)
|
1994-03-29 |
1996-04-26 |
Rhone Poulenc Rorer Sa |
Virus recombinants, préparation et utilisation en thérapie génique.
|
US5851806A
(en)
*
|
1994-06-10 |
1998-12-22 |
Genvec, Inc. |
Complementary adenoviral systems and cell lines
|
DE69535178T2
(de)
*
|
1994-06-10 |
2006-12-14 |
Genvec, Inc. |
Adenoviren-vektor systeme und zelllinien
|
FR2722507B1
(fr)
*
|
1994-07-12 |
1996-08-14 |
Rhone Poulenc Rorer Sa |
Adenovirus comportant un gene codant pour une no synthase
|
FR2723697B1
(fr)
*
|
1994-08-17 |
1996-09-20 |
Rhone Poulenc Rorer Sa |
Methode de traitement de la restenose par la therapie genique
|
US6465253B1
(en)
|
1994-09-08 |
2002-10-15 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US5846782A
(en)
*
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
WO1996015245A1
(en)
*
|
1994-11-11 |
1996-05-23 |
Arch Development Corporation |
A process of inhibiting non-neoplastic pathological cell proliferation
|
US5770442A
(en)
*
|
1995-02-21 |
1998-06-23 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral fiber protein and methods of using same
|
US6127525A
(en)
*
|
1995-02-21 |
2000-10-03 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral coat protein and methods of using same
|
US5792453A
(en)
*
|
1995-02-28 |
1998-08-11 |
The Regents Of The University Of California |
Gene transfer-mediated angiogenesis therapy
|
US6306830B1
(en)
|
1996-09-05 |
2001-10-23 |
The Regents Of The University Of California |
Gene therapy for congestive heart failure
|
US20030148968A1
(en)
*
|
1995-02-28 |
2003-08-07 |
Hammond H. Kirk |
Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
|
CN100569297C
(zh)
*
|
1995-02-28 |
2009-12-16 |
加利福尼亚大学董事会 |
基因转移介导的血管形成疗法
|
US6752987B1
(en)
|
1995-02-28 |
2004-06-22 |
The Regents Of The University Of California |
Adenovirus encoding human adenylylcyclase (AC) VI
|
FR2732357B1
(fr)
*
|
1995-03-31 |
1997-04-30 |
Rhone Poulenc Rorer Sa |
Vecteurs viraux et utilisation pour le traitement des desordres hyperproliferatifs, notamment de la restenose
|
DE69638058D1
(de)
|
1995-06-15 |
2009-11-26 |
Crucell Holland Bv |
Verpackungssysteme für humane rekombinante Adenoviren zur Gentherapie
|
US6783980B2
(en)
|
1995-06-15 |
2004-08-31 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
US5795872A
(en)
*
|
1995-09-19 |
1998-08-18 |
Pharmadigm, Inc. |
DNA construct for immunization
|
US7169764B1
(en)
|
1995-10-05 |
2007-01-30 |
Arch Development Corporation |
Promoter for smooth muscle cell expression
|
US6090618A
(en)
*
|
1996-10-07 |
2000-07-18 |
Arch Development Corporation |
DNA constructs and viral vectors comprising a smooth muscle promoter
|
US6121246A
(en)
*
|
1995-10-20 |
2000-09-19 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for treating ischemic tissue
|
EP0862644A2
(de)
*
|
1995-11-17 |
1998-09-09 |
Franz, Wolfgang-M., Dr. |
Gentherapeutisches nukleinsäurekonstrukt, seine herstellung und verwendung zur behandlung von herzerkrankungen
|
US20010009904A1
(en)
*
|
1997-12-30 |
2001-07-26 |
Jon A. Wolff |
Process of delivering a polynucleotide to a cell via the vascular system
|
IL125756A
(en)
|
1996-02-15 |
2003-05-29 |
Biosense Inc |
Catheter for use in surgery
|
AU2458597A
(en)
|
1996-07-17 |
1998-02-09 |
Medtronic, Inc. |
System for genetically treating cardiac conduction disturbances
|
WO1998002040A1
(en)
|
1996-07-17 |
1998-01-22 |
Medtronic, Inc. |
System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
IL132537A0
(en)
*
|
1997-04-25 |
2001-03-19 |
Collateral Therapeutics |
Truncated vegf-related proteins
|
US6696423B1
(en)
|
1997-08-29 |
2004-02-24 |
Biogen, Inc. |
Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
|
BR9813930A
(pt)
|
1997-11-06 |
2006-12-19 |
Chiron Spa |
antìgeno neisserial
|
US6151525A
(en)
|
1997-11-07 |
2000-11-21 |
Medtronic, Inc. |
Method and system for myocardial identifier repair
|
US7031775B2
(en)
|
1997-11-07 |
2006-04-18 |
Medtronic, Inc. |
Method and system for myocardial infarction repair
|
US6775574B1
(en)
|
1997-11-07 |
2004-08-10 |
Medtronic, Inc. |
Method and system for myocardial infarction repair
|
AU1979599A
(en)
|
1998-01-14 |
1999-08-02 |
Chiron S.P.A. |
(neisseria meningitidis) antigens
|
ES2293473T3
(es)
|
1998-02-05 |
2008-03-16 |
Biosense Webster, Inc. |
Administracion intracardiaca de farmaco.
|
IL137616A0
(en)
|
1998-02-06 |
2001-07-24 |
Collateral Therapeutics Inc |
Variants of vegf-a
|
EP2261347A3
(de)
|
1998-05-01 |
2012-01-11 |
Novartis Vaccines and Diagnostics, Inc. |
Antigene und Zusammensetzungen gegen Neisseria meningitidis
|
US20030017138A1
(en)
|
1998-07-08 |
2003-01-23 |
Menzo Havenga |
Chimeric adenoviruses
|
AU5819599A
(en)
*
|
1998-09-11 |
2000-04-03 |
Regents Of The University Of California, The |
Recombinant adenovirus for tissue specific expression in heart
|
US6929946B1
(en)
|
1998-11-20 |
2005-08-16 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
CN100392082C
(zh)
|
1999-04-30 |
2008-06-04 |
启龙股份公司 |
保守的奈瑟球菌抗原
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
ES2541830T3
(es)
|
1999-10-29 |
2015-07-27 |
Novartis Vaccines And Diagnositics S.R.L. |
Péptidos antigénicos de Neisseria
|
WO2001048164A2
(en)
|
1999-12-27 |
2001-07-05 |
The Regents Of The University Of California |
Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
|
PT1248647E
(pt)
|
2000-01-17 |
2010-11-18 |
Novartis Vaccines & Diagnostics Srl |
Vacina de vesícula da membrana externa (omv) compreendendo proteínas de membrana externa de n. meningitidis do serogrupo b
|
CA2412847A1
(en)
*
|
2000-06-30 |
2002-01-10 |
Collateral Therapeutics, Inc. |
Dual recombinant gene therapy compositions and methods of use
|
FR2811678B1
(fr)
*
|
2000-07-12 |
2002-09-27 |
Inst Nat Sante Rech Med |
Promoteur specifique du myocarde
|
WO2002011769A1
(en)
|
2000-08-04 |
2002-02-14 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US7235233B2
(en)
|
2000-09-26 |
2007-06-26 |
Crucell Holland B.V. |
Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
|
WO2002031138A1
(fr)
*
|
2000-10-06 |
2002-04-18 |
Dnavec Research Inc. |
Vecteur de paramyxovirus permettant de transferer un gene etranger dans le muscle squelettique
|
EP2277895B1
(de)
|
2000-10-27 |
2013-08-14 |
Novartis Vaccines and Diagnostics S.r.l. |
Nukleinsäure und Proteine von Gruppen A und B Streptokokken
|
JP2005501802A
(ja)
*
|
2001-01-23 |
2005-01-20 |
ボストン サイエンティフィック コーポレイション |
虚血心筋を処置するための限局性心筋注入方法
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
DE60236646D1
(de)
|
2001-04-13 |
2010-07-22 |
Human Genome Sciences Inc |
Anti-VEGF-2 Antikörper
|
EP1451306A1
(de)
*
|
2001-11-06 |
2004-09-01 |
Medtronic, Inc. |
Verfahren und system zur operativen versorgung nach myokardinfarkt
|
US20050106162A1
(en)
|
2001-12-12 |
2005-05-19 |
Guido Grandi |
Immunisation against chlamydia trachomatis
|
US20030158112A1
(en)
|
2002-02-15 |
2003-08-21 |
Johns Hopkins University School Of Medicine |
Selective induction of apoptosis to treat ocular disease
|
IL164803A0
(en)
|
2002-04-25 |
2005-12-18 |
Crucell Holland Bv |
Means and methods for the production of adenovirusvectors
|
US20040044329A1
(en)
*
|
2002-08-29 |
2004-03-04 |
Trudell Leonard A. |
Catheter for cardiac injection and method for delivery of therapeutic agents to specified tissues
|
WO2004073484A2
(en)
*
|
2003-02-24 |
2004-09-02 |
Yossi Gross |
Fully-implantable cardiac recovery system
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US7818040B2
(en)
*
|
2003-09-05 |
2010-10-19 |
Medtronic, Inc. |
Deflectable medical therapy delivery device having common lumen profile
|
CN1621094A
(zh)
*
|
2003-11-26 |
2005-06-01 |
犹太大学阿尔伯特爱因斯坦医学院 |
用于调节平滑肌张力的基因转移
|
US7840263B2
(en)
|
2004-02-27 |
2010-11-23 |
Cardiac Pacemakers, Inc. |
Method and apparatus for device controlled gene expression
|
ES2407465T3
(es)
|
2004-03-29 |
2013-06-12 |
Galpharma Co., Ltd. |
Nueva proteína galectina 9 modificada y uso de la misma
|
US7764995B2
(en)
|
2004-06-07 |
2010-07-27 |
Cardiac Pacemakers, Inc. |
Method and apparatus to modulate cellular regeneration post myocardial infarct
|
US7828711B2
(en)
*
|
2004-08-16 |
2010-11-09 |
Cardiac Pacemakers, Inc. |
Method and apparatus for modulating cellular growth and regeneration using ventricular assist device
|
ITRM20040569A1
(it)
*
|
2004-11-18 |
2005-02-18 |
Biogem S C A R L Biotecnologie |
Modello animale per lo studio di sostanze ad attivita' cardioterapeutica ed anti-ipertensiva.
|
US7981065B2
(en)
|
2004-12-20 |
2011-07-19 |
Cardiac Pacemakers, Inc. |
Lead electrode incorporating extracellular matrix
|
US8060219B2
(en)
|
2004-12-20 |
2011-11-15 |
Cardiac Pacemakers, Inc. |
Epicardial patch including isolated extracellular matrix with pacing electrodes
|
US20070265221A1
(en)
*
|
2006-05-09 |
2007-11-15 |
Weiss Robert G |
Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure
|
DK2054431T3
(da)
|
2006-06-09 |
2012-01-02 |
Novartis Ag |
Konformere af bakterielle adhæsiner
|
WO2008103336A1
(en)
*
|
2007-02-21 |
2008-08-28 |
Cook Incorporated |
Methods for intravascular engraftment in heart
|
AU2008350903B2
(en)
*
|
2008-02-19 |
2015-04-02 |
Celladon Corporation |
Compositions for enhanced uptake of viral vectors in the myocardium
|
AU2017326535B2
(en)
*
|
2016-09-16 |
2023-08-24 |
Icahn School Of Medicine At Mount Sinai |
Cell-specific expression of modrna
|